Norway· NO-ID_AF5A13CA-3271-4D8A-BCDF-C43E324B7F8B
Zeposia
A ozanimod product containing ozanimod, registered in Norway by Bristol-Myers Squibb Pharma EEIG (1). The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Ozanimod is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AE02 (ozanimod), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Ozanimod · ATC L04AE02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ozanimod costs, country by country.
Normalised to the WHO defined daily dose (0.92 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ozanimod · price per daily dose (0.92 mg)
USD · FX 28 Sept 2026
- CH Switzerland$85.78
The record
At a glance
FEST (Norway)- Active substance
- Ozanimod
- Manufacturer
- Bristol-Myers Squibb Pharma EEIG (1)
- Country
- Norway (NO)
- ATC code
- L04AE02
- ATC class
- Ozanimod
- Defined daily dose
- 0.92 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 1
- no_merkevare_idID_AF5A13CA-3271-4D8A-BCDF-C43E324B7F8B
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
852 interactions on record for ozanimod.
Graded by severity as the source publishes them — 578 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ozanimod · interactions on record
852 records
- 578 severe
- 271 moderate
- 3 minor
Most severe, free to view
- FamotidineA02BA03severe
- PapaverineA03AD01severe
- IsomethepteneA03AX10severe
- CisaprideA03FA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ozanimod in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandZeposia 0.46 mg, HartkapselnBristol-Myers Squibb SA
- United KingdomZeposia 0.46mg capsulesBristol-Myers Squibb Pharmaceuticals Ltd
- NetherlandsZeposia 0,46 mg capsule, hardBristol-Myers Squibb Pharma EEIG
- CzechiaZEPOSIABristol-Myers Squibb Pharma EEIG, Dublin
- IrelandZeposia 0.23 mg hard capsules Zeposia 0.46 mg hard capsulesBristol-Myers Squibb Pharma EEIG
- IcelandZeposiaBristol-Myers Squibb Pharma EEIG*
- ItalyZEPOSIA*28 cps 0,92 mgBRISTOL M.SQUIBB PHARMA EEIG
- PolandZeposiaBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Zeposia
- Liechtenstein · Zeposia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4a52419f-23d9-41eb-b80f-56f031965147 GET /v1/drugs/4a52419f-23d9-41eb-b80f-56f031965147?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Ozanimod",
"merkevare_id": "ID_AF5A13CA-3271-4D8A-BCDF-C43E324B7F8B",
"name_form_strength": "Zeposia kaps 0,46 mg",
"prescription_group": "C"
}See everything about ozanimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.